[Skip to Content]
[Skip to Content Landing]
Views 366
Citations 0
Research Letter
March 2018

Laboratory Eligibility Criteria as Potential Barriers to Participation by Black Men in Prostate Cancer Clinical Trials

Author Affiliations
  • 1Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, Massachusetts
  • 2Harvard Radiation Oncology Program, Boston, Massachusetts
JAMA Oncol. 2018;4(3):413-414. doi:10.1001/jamaoncol.2017.4658

Black patients are underrepresented in clinical trials despite widespread efforts to increase minority participation.1,2 Eligibility criteria may disproportionately prevent black patients from participating due to racial variations in laboratory values. We studied this potential barrier by examining clinical trials in prostate cancer, a disease in which black men face higher incidence and mortality.3